Emerald Overview

  • Year Founded
  • 2024

Year Founded

  • Status
  • Private

  • Employees
  • 25

Employees

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $928K

  • Investors
  • 14

Emerald General Information

Description

Developer of a preventive health membership service platform designed to support early detection, ongoing monitoring, and data-driven personal health management. The company's platform integrates lab-based biomarker testing, clinical assessments, lifestyle and wearable data, and personalized action plans reviewed by medical professionals, enabling the preventive healthcare market with continuous health insights, consolidated data access, structured guidance, and improved long-term decision-making based on comprehensive biological information.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 71-75 Shelton Street
  • Covent Garden
  • London WC2H 9JQ
  • England, United Kingdom
Primary Industry
Clinics/Outpatient Services
Other Industries
Application Software
Other Healthcare Technology Systems
Corporate Office
  • 71-75 Shelton Street
  • Covent Garden
  • London WC2H 9JQ
  • England, United Kingdom

Emerald Timeline

20252026
Date FoundedFinancing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Emerald Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Early Stage VC 20-Oct-2026 $928K Completed Generating Revenue
4. Grant 20-Oct-2026 Completed Generating Revenue
3. Seed Round 29-Jan-2026 Completed Generating Revenue
2. Grant 01-Aug-2025 $133K $396K Completed Generating Revenue
1. Equity Crowdfunding 26-Feb-2025 $396K $396K Completed Generating Revenue
To view Emerald’s complete valuation and funding history, request access »

Emerald Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series Pre Seed Preferred Shares
Ordinary
Ordinary 134,190 $0.000013 $6.07 $6.07 1x $6.07 10.02%
To view Emerald’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Emerald Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Emerald Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds
Highgoal Capital Management Venture Capital Minority
Sequel Holdings PE/Buyout Minority
Boost Capital Partners Venture Capital Minority
Granatus Ventures Venture Capital Minority
Angel (individual) Minority
You’re viewing 5 of 14 investors. Get the full list »

Emerald FAQs

  • When was Emerald founded?

    Emerald was founded in 2024.

  • Where is Emerald headquartered?

    Emerald is headquartered in London, United Kingdom.

  • What is the size of Emerald?

    Emerald has 25 total employees.

  • What industry is Emerald in?

    Emerald’s primary industry is Clinics/Outpatient Services.

  • Is Emerald a private or public company?

    Emerald is a Private company.

  • What is Emerald’s current revenue?

    The current revenue for Emerald is .

  • How much funding has Emerald raised over time?

    Emerald has raised $3.41M.

  • Who are Emerald’s investors?

    Highgoal Capital Management, Sequel Holdings, Boost Capital Partners, Granatus Ventures, and are 5 of 14 investors who have invested in Emerald.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process